The Belgian Competition Authority confirms that Belgian merger control rules apply to the creation of loco-regional hospital networks pursuant to the Act of 28 February 2019
Following the recent legislative amendment obliging hospitals to establish and be part of a loco-regional hospital network, the Belgian Competition Authority published on 22 July 2020 a note setting out the principles that will guide it when assessing the establishment of hospital networks and their possible qualification as a concentration under competition law.
The European Commission is collecting data and feedback from stakeholders about the European Union’s current rules on packaging and packaging waste.
On 23 April 2020, the Court of Justice of the EU clarified earlier case law that obliges each airline to indicate in its initial online price offer(s), the airfare and, separately, the taxes, charges, surcharges and fees that are unavoidable and foreseeable.
Belgian federal government restricts the sale of personal protective equipment and medical devices that can be used in the fight against Covid-19 – Updated
On 23 March 2020, a Ministerial Decree on special measures in the context of the SARS-CoV-2 pandemic on the basis of Book XVIII of the Code of Economic Law was adopted by the Belgian Minister of Economic Affairs, which restricts both the retail and wholesale distribution of certain types of personal protective equipment, as well as of medical devices used for treating Covid-19 patients.
On 30 April 2020, the European Commission adopted three implementing regulations allowing temporary derogations from the strict cartel prohibition provided for by EU competition law in three specific agricultural sectors: dairy, potato and live plants and flowers.
On 19 February 2020, the European Commission released its White Paper on Artificial Intelligence, which sets out policy options on how to achieve the double goal of (1) promoting the update of AI and (2) addressing the risks associated with certain uses of this technology.
On 8 April 2020, the Belgian federal agency for medicines and health products adopted a consolidated version of its decision taking the following urgent measures for certain listed medicines to avoid medicine shortages during the SARS-CoV-2 pandemic.
In its ruling of 30 January 2020, the Court of Justice of the European Union (‘CJEU’) has clarified for the first time the criteria governing whether a reverse payment settlement agreement concerning a dispute between the holder of a pharmaceutical patent and a manufacturer of generic medicines is contrary to EU competition law.
The DPA approves a draft Act prohibiting life and health insurers from processing health sensor data
The Belgian data protection authority has approved a draft Act that prohibits life and health insurers from processing the health sensor data of their insurance holders.
New rules in the Walloon Region and their substantial consequences for franchise and commercial lease agreements: do you comply with them?
Since the transfer of the legislative competence for commercial leases from the federal to the regional level, the Walloon legislator has already made use of its new competence by amending the Act of 30 April 1951 on commercial leases in several aspects.